We are committed to finding a cure for WM.

Video: Dr. Dimopoulos Reflects on Ibrutinib Plus Rituximab in Waldenstrom Macroglobulinemia

Source: https://www.onclive.com/onclive-tv/dr-dimopoulos-reflects-on-ibrutinib-plus-rituximab-in-waldenstrom-macroglobulinemia

Meletios Dimopoulos, MD, professor and chairman, Department of Clinical Therapeutics at the University of Athens School of Medicine, Athens, Greece, discusses the impact of the results from the iNNOVATE study of ibrutinib (Imbruvica) plus rituximab (Rituxan) in patients… Continue reading

Cure Magazine covers WM

Cure Magazine’s special issue on Rare Cancers, published on August 1, 2018, includes an article entitled “Waldenstrom Macroglobulinemia: The Discovery and What Lies Ahead”.

The article goes on to describe WM, its rarity, and recent advances in treatment options for… Continue reading

Article: Exploring Use of Ibrutinib/Rituximab Combination for Waldenström Macroglobulinemia

JULY 06, 2018
Kristi Rosa

A type of non-Hodgkin lymphoma, Waldenström macroglobulinemia is a rare, slow-growing lymphoproliferative disorder that is estimated to affect only 1,000 to 1,500 individuals each year in the… Continue reading

Book Recommendations


We are compiling a reading list of books that our members have recommended. Please feel free to send us titles that you have found inspiring and resourceful.



“Things I wish I’d Known – Cancer Caregivers… Continue reading